Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- 2019-nCoV Vaccine mRNA-1273 3
- 2019-nCoV Vaccine MRNA-1273 2
- Acute Disease 4
- Adolescent 37
- Adult 44
- Adverse Drug Reaction Reporting Systems 4
- Advisory Committees 19
- Aged 25
- Aged, 80 and over 7
- Age Factors 3
- Ambulatory Care Facilities 2
- Antibodies, Viral 3
- Antiviral Agents 3
- Article 9
- Asymptomatic Diseases 3
- BetacoronaVirus 11
- BNT162 Vaccine 5
- Case-Control Studies 3
- Centers for Disease Control and Prevention, U.S. 2
- Child 23
- Child, Preschool 17
- Clinical Laboratory Services 3
- Contact Tracing 3
- CoronaVirus Infections 28
- Coronavirus Infections 4
- CoronaVirus Infections/Diagnosis 2
- Coronavirus Infections/prevention & control 15
- CoronaVirus Infections/Prevention & Control 2
- COVID-19 57
- COVID-19 Vaccines 46
- COVID-19 Vaccines/supply & distribution 2
- COVID-19/prevention & control 16
- COVID-19/Prevention & Control 2
- Cross-Sectional Studies 2
- Cross Infection 2
- Drug Approval 9
- Emergency Service, Hospital 3
- Ethics, Medical 3
- Ethnicity 4
- Family Characteristics 4
- Female 36
- Full Report 7
- Health Care Rationing 4
- Health Equity 3
- Health Personnel 3
- Health Planning Guidelines 2
- Hospitalization 40
- Hospital Mortality 3
- Humans 70
- Immunization 10
- Immunization, Secondary 9
- Immunization/standards 3
- Immunization Programs 3
- Immunization Schedule 4
- Immunocompromised Host 3
- Incidence 2
- Infant 16
- Infant, Newborn 8
- Influenza 2
- Influenza, Human 14
- Influenza A virus 2
- Influenza A Virus, H1N1 Subtype 5
- Influenza A Virus, H3N2 Subtype 3
- Influenza B virus 3
- Influenza Vaccines 18
- Laboratories 3
- Logistic Models 3
- Male 34
- Middle Aged 31
- Outpatients 2
- Pandemics 22
- Patient Safety 11
- Personnel, Hospital 3
- Pneumonia, Viral 15
- Population Surveillance 5
- Practice Guidelines as Topic 6
- Pregnancy 5
- Pregnancy Complications, Infectious 2
- Prevalence 6
- Prospective Studies 6
- Public Health Surveillance 2
- Respiratory Tract Infections 5
- Risk Assessment 3
- Risk Factors 8
- RNA, Messenger 4
- SARS-CoV-2 27
- Seasons 7
- Severity of Illness Index 7
- Time Factors 3
- Treatment Outcome 4
- United States 7
- Vaccination 32
- Vaccination Coverage 3
- Vaccine Efficacy 5
- Vaccines, Combined 3
- Vaccines, Inactivated 3
- Vaccines, Synthetic 8
- Viral Vaccine 3
- Viral Vaccines 8
- Young Adult 23
Personal Author
Corporate Author
- Arkansas. Department of Arkansas. Department of Health. 1
- Arkansas. Department of Health. 5
- Atlanta Veterans Affairs Medical Center, Atlanta, Georgia 3
- Atlanta Veterans Affairs Medical Center. Emerging Infections Program. 1
- Baylor Scott & White Health. 4
- Baystate Medical Center, Springfield, Massachusetts 1
- Baystate Medical Center, Springfield, Massachusetts. 2
- Baystate Medical Center. 2
- Beth Israel Deaconess Medical Center. 3
- California Emerging Infections Program 3
- California Emerging Infections Program. 6
- CDC COVID-19 Emergency Response Team 3
- CDC COVID-19 Emergency Response Team. 1
- CDC COVID-19 Response Team 6
- CDC COVID-19 Response Team. 14
- CDC COVID-NET Surveillance Team. 2
- CDC COVID-NET Team. 4
- CDC COVID- Response Team. 2
- Centers for Disease Control and Prevention (U.S.) 2
- Centers for Disease Control and Prevention (U.S.). Epidemic Intelligence Service. 8
- Centers for Disease Control and Prevention (U.S.)Career Epidemiology Field Officer Program. 4
- Centers for Disease Control and Prevention (U.S.)Epidemic Intelligence Service. 4
- Cleveland Clinic. 2
- Colorado. Department of Public Health and Environment. 6
- Colorado Dept. of Public Health and Environment 2
- COVID-19 Vaccine Safety Technical (VaST) Work Group. 7
- COVID-NET Surveillance Team 14
- COVID-NET Surveillance Team. 4
- Eagle Global Scientific. 2
- Emory University School of Medicine 3
- Emory University School of Medicine. 5
- Epidemic Intelligence Service 2
- Franny Strong Foundation (West Bloomfield, Michigan) 2
- General Dynamics Information Technology 2
- General Dynamics Information Technology, Atlanta, Georgia 2
- General Dynamics Information Technology. 6
- Georgia Emerging Infections Program 2
- Georgia Emerging Infections Program. 5
- Hennepin County Medical Center. 5
- Iowa. Department of Public Health. 4
- IVY Network 9
- IVY Network. 4
- IVY Network Investigators 3
- Johns Hopkins Hospital. 5
- Kaiser Permanente Colorado. Institute for Health Research. 7
- Marshfield Clinic Research Institute. 2
- Maryland. Department of Health. 6
- McMaster University. Faculty of Health Sciences. Department of Health Research Methods, Evidence, and Impact. 6
- Michigan. Department of Health and Human Services. 7
- Minnesota. Department of Health. 8
- Minnesota Dept. of Health 2
- Montefiore Medical Center and Albert Einstein College of Medicine. 3
- New Mexico. Department of Health. 3
- New Mexico Department of Health. 2
- New Mexico Dept. of Health 2
- New Mexico Emerging Infections Program, Albuquerque, New Mexico 2
- New Mexico Emerging Infections Program, Albuquerque, New Mexico. 3
- New York (State). Department of Health. 4
- New York. State Department of Health. 3
- New York State Dept. of Health 2
- Ohio. Department of Health. 6
- Ohio Dept. of Health 2
- Ohio State University. Wexner Medical Center. 2
- Ohio State University Wexner Medical Center. 2
- Oregon Health & Science University Hospital. 3
- Oregon Health Authority. Public Health Division. 7
- Oregon Health Authority Public Health Div. 2
- Ronald Reagan-UCLA Medical Center. 3
- Salt Lake County (Utah). Health Department. 7
- Stanford University School of Medicine. 12
- Texas A&M University. College of Medicine. 2
- Texas A&M University College of Medicine. 2
- United States. Advisory Committee on Immunization Practices. 13
- United States. Advisory Committee on Immunization Practices. Influenza Work Group. 7
- University of Arizona. College of Medicine. 4
- University of California, Berkeley. School of Public Health. 2
- University of Colorado School of Medicine (Aurora) 2
- University of Colorado School of Medicine, Aurora, Colorado 3
- University of Iowa. 3
- University of Miami. 2
- University of Michigan School of Public Health. 3
- University of New Mexico. New Mexico Emerging Infections Program 2
- University of Rochester. School of Medicine and Dentistry. 4
- University of Rochester Medical Center. Rochester Emerging Infections Program. 2
- University of Rochester School of Medicine and Dentistry 2
- University of Rochester School of Medicine and Dentistry. 4
- University of Washington. 7
- University of Washington School of Medicine. 3
- Utah. Department of Health. 2
- Vanderbilt University Medical Center 2
- Vanderbilt University Medical Center. 12
- Vanderbilt University School of Medicine. 11
- Veterans Affairs Medical Center (Atlanta, Ga.). 2
- Wake Forest University. Baptist Medical Center. 2
- Wake Forest University Baptist Medical Center. 3
- Washington University. 2
- Watts Healthcare Corporation. 4
- Yale University. School of Public Health. Connecticut Emerging Infections Program. 3
- Yale University. School of Public Health.Connecticut Emerging Infections Program. 2
- Yale University School of Public Health Connecticut Emerging Infections Program 2
Place as Subject
- Alabama 2
- Arizona 2
- California 9
- Colorado 11
- Connecticut 7
- Davidson County, TN 1
- Florida 1
- Georgia 8
- Germanu 1
- Indiana 2
- Iowa 6
- Los Angeles, CA 2
- Louisiana 2
- Maryland 11
- Massachusetts 2
- Michigan 8
- Minnesota 11
- Missouri 1
- New Jersey 1
- New Mexico 9
- New York 9
- New York City, NY 2
- North Carolina 4
- Ohio 9
- Oregon 8
- OregonTennessee 1
- Seattle, WA 2
- Tennessee 15
- Texas 1
- U.S. 7
- United States 47
- Utah 10
- Washington 2
- Wisconsin 3
Resource Type General
Resource Type Specific
- Conference Publications 16
- Guidance 1
- Guideline 1
- QuickStats 1
- Statistics 1
- Vital Signs 1
Keywords
- acute respiratory illness 1
- Buprenorphine 1
- coronavirus disease 1
- COVID-19 1
- COVID-19 Testing 1
- COVID-19 vaccines 1
- COVID-19–associated hospitalizations 1
- disease transmission 1
- Emergency Use Authorization 1
- household transmission 1
- Humans 1
- influenza 1
- Influenza, Human 1
- Methadone 1
- Mortality 1
- Naltrexone 1
- Pandemics 1
- pandemics 1
- presenteeism 1
- race and ethnicity 1
- respiratory infections 1
- SARS-CoV-2 2
- SARS-COV-2 1
- secondary infection risk 1
- severe acute respiratory syndrome coronavirus 2 1
- teleworking 1
- Treatment 1
- trends 1
- United States 1
- Vaccine safety 1
- viral culture 1
- viruses 1
- workplaces 1
Select all docs (Max 200)
1 -
20 of 112 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- 2019-nCoV Vaccine mRNA-1273 (3)
- 2019-nCoV Vaccine MRNA-1273 (2)
- Acute Disease (4)
- Adolescent (37)
- Adult (44)
- Adverse Drug Reaction Reporting Systems (4)
- Advisory Committees (19)
- Aged (25)
- Aged, 80 and over (7)
- Age Factors (3)
- Ambulatory Care Facilities (2)
- Antibodies, Viral (3)
- Antiviral Agents (3)
- Article (9)
- Asymptomatic Diseases (3)
- BetacoronaVirus (11)
- BNT162 Vaccine (5)
- Case-Control Studies (3)
- Centers for Disease Control and Prevention, U.S. (2)
- Child (23)
- Child, Preschool (17)
- Clinical Laboratory Services (3)
- Contact Tracing (3)
- CoronaVirus Infections (28)
- Coronavirus Infections (4)
- CoronaVirus Infections/Diagnosis (2)
- Coronavirus Infections/prevention & control (15)
- CoronaVirus Infections/Prevention & Control (2)
- COVID-19 (57)
- COVID-19 Vaccines (46)
- COVID-19 Vaccines/supply & distribution (2)
- COVID-19/prevention & control (16)
- COVID-19/Prevention & Control (2)
- Cross-Sectional Studies (2)
- Cross Infection (2)
- Drug Approval (9)
- Emergency Service, Hospital (3)
- Ethics, Medical (3)
- Ethnicity (4)
- Family Characteristics (4)
- Female (36)
- Full Report (7)
- Health Care Rationing (4)
- Health Equity (3)
- Health Personnel (3)
- Health Planning Guidelines (2)
- Hospitalization (40)
- Hospital Mortality (3)
- Humans (70)
- Immunization (10)
- Immunization, Secondary (9)
- Immunization/standards (3)
- Immunization Programs (3)
- Immunization Schedule (4)
- Immunocompromised Host (3)
- Incidence (2)
- Infant (16)
- Infant, Newborn (8)
- Influenza (2)
- Influenza, Human (14)
- Influenza A virus (2)
- Influenza A Virus, H1N1 Subtype (5)
- Influenza A Virus, H3N2 Subtype (3)
- Influenza B virus (3)
- Influenza Vaccines (18)
- Laboratories (3)
- Logistic Models (3)
- Male (34)
- Middle Aged (31)
- Outpatients (2)
- Pandemics (22)
- Patient Safety (11)
- Personnel, Hospital (3)
- Pneumonia, Viral (15)
- Population Surveillance (5)
- Practice Guidelines as Topic (6)
- Pregnancy (5)
- Pregnancy Complications, Infectious (2)
- Prevalence (6)
- Prospective Studies (6)
- Public Health Surveillance (2)
- Respiratory Tract Infections (5)
- Risk Assessment (3)
- Risk Factors (8)
- RNA, Messenger (4)
- SARS-CoV-2 (27)
- Seasons (7)
- Severity of Illness Index (7)
- Time Factors (3)
- Treatment Outcome (4)
- United States (7)
- Vaccination (32)
- Vaccination Coverage (3)
- Vaccine Efficacy (5)
- Vaccines, Combined (3)
- Vaccines, Inactivated (3)
- Vaccines, Synthetic (8)
- Viral Vaccine (3)
- Viral Vaccines (8)
- Young Adult (23)
- Arkansas. Department of Arkansas. Department of Health. (1)
- Arkansas. Department of Health. (5)
- Atlanta Veterans Affairs Medical Center, Atlanta, Georgia (3)
- Atlanta Veterans Affairs Medical Center. Emerging Infections Program. (1)
- Baylor Scott & White Health. (4)
- Baystate Medical Center, Springfield, Massachusetts (1)
- Baystate Medical Center, Springfield, Massachusetts. (2)
- Baystate Medical Center. (2)
- Beth Israel Deaconess Medical Center. (3)
- California Emerging Infections Program (3)
- California Emerging Infections Program. (6)
- CDC COVID-19 Emergency Response Team (3)
- CDC COVID-19 Emergency Response Team. (1)
- CDC COVID-19 Response Team (6)
- CDC COVID-19 Response Team. (14)
- CDC COVID-NET Surveillance Team. (2)
- CDC COVID-NET Team. (4)
- CDC COVID- Response Team. (2)
- Centers for Disease Control and Prevention (U.S.) (2)
- Centers for Disease Control and Prevention (U.S.). Epidemic Intelligence Service. (8)
- Centers for Disease Control and Prevention (U.S.)Career Epidemiology Field Officer Program. (4)
- Centers for Disease Control and Prevention (U.S.)Epidemic Intelligence Service. (4)
- Cleveland Clinic. (2)
- Colorado. Department of Public Health and Environment. (6)
- Colorado Dept. of Public Health and Environment (2)
- COVID-19 Vaccine Safety Technical (VaST) Work Group. (7)
- COVID-NET Surveillance Team (14)
- COVID-NET Surveillance Team. (4)
- Eagle Global Scientific. (2)
- Emory University School of Medicine (3)
- Emory University School of Medicine. (5)
- Epidemic Intelligence Service (2)
- Franny Strong Foundation (West Bloomfield, Michigan) (2)
- General Dynamics Information Technology (2)
- General Dynamics Information Technology, Atlanta, Georgia (2)
- General Dynamics Information Technology. (6)
- Georgia Emerging Infections Program (2)
- Georgia Emerging Infections Program. (5)
- Hennepin County Medical Center. (5)
- Iowa. Department of Public Health. (4)
- IVY Network (9)
- IVY Network. (4)
- IVY Network Investigators (3)
- Johns Hopkins Hospital. (5)
- Kaiser Permanente Colorado. Institute for Health Research. (7)
- Marshfield Clinic Research Institute. (2)
- Maryland. Department of Health. (6)
- McMaster University. Faculty of Health Sciences. Department of Health Research Methods, Evidence, and Impact. (6)
- Michigan. Department of Health and Human Services. (7)
- Minnesota. Department of Health. (8)
- Minnesota Dept. of Health (2)
- Montefiore Medical Center and Albert Einstein College of Medicine. (3)
- New Mexico. Department of Health. (3)
- New Mexico Department of Health. (2)
- New Mexico Dept. of Health (2)
- New Mexico Emerging Infections Program, Albuquerque, New Mexico (2)
- New Mexico Emerging Infections Program, Albuquerque, New Mexico. (3)
- New York (State). Department of Health. (4)
- New York. State Department of Health. (3)
- New York State Dept. of Health (2)
- Ohio. Department of Health. (6)
- Ohio Dept. of Health (2)
- Ohio State University. Wexner Medical Center. (2)
- Ohio State University Wexner Medical Center. (2)
- Oregon Health & Science University Hospital. (3)
- Oregon Health Authority. Public Health Division. (7)
- Oregon Health Authority Public Health Div. (2)
- Ronald Reagan-UCLA Medical Center. (3)
- Salt Lake County (Utah). Health Department. (7)
- Stanford University School of Medicine. (12)
- Texas A&M University. College of Medicine. (2)
- Texas A&M University College of Medicine. (2)
- United States. Advisory Committee on Immunization Practices. (13)
- United States. Advisory Committee on Immunization Practices. Influenza Work Group. (7)
- University of Arizona. College of Medicine. (4)
- University of California, Berkeley. School of Public Health. (2)
- University of Colorado School of Medicine (Aurora) (2)
- University of Colorado School of Medicine, Aurora, Colorado (3)
- University of Iowa. (3)
- University of Miami. (2)
- University of Michigan School of Public Health. (3)
- University of New Mexico. New Mexico Emerging Infections Program (2)
- University of Rochester. School of Medicine and Dentistry. (4)
- University of Rochester Medical Center. Rochester Emerging Infections Program. (2)
- University of Rochester School of Medicine and Dentistry (2)
- University of Rochester School of Medicine and Dentistry. (4)
- University of Washington. (7)
- University of Washington School of Medicine. (3)
- Utah. Department of Health. (2)
- Vanderbilt University Medical Center (2)
- Vanderbilt University Medical Center. (12)
- Vanderbilt University School of Medicine. (11)
- Veterans Affairs Medical Center (Atlanta, Ga.). (2)
- Wake Forest University. Baptist Medical Center. (2)
- Wake Forest University Baptist Medical Center. (3)
- Washington University. (2)
- Watts Healthcare Corporation. (4)
- Yale University. School of Public Health. Connecticut Emerging Infections Program. (3)
- Yale University. School of Public Health.Connecticut Emerging Infections Program. (2)
- Yale University School of Public Health Connecticut Emerging Infections Program (2)
- Alabama (2)
- Arizona (2)
- California (9)
- Colorado (11)
- Connecticut (7)
- Davidson County, TN (1)
- Florida (1)
- Georgia (8)
- Germanu (1)
- Indiana (2)
- Iowa (6)
- Los Angeles, CA (2)
- Louisiana (2)
- Maryland (11)
- Massachusetts (2)
- Michigan (8)
- Minnesota (11)
- Missouri (1)
- New Jersey (1)
- New Mexico (9)
- New York (9)
- New York City, NY (2)
- North Carolina (4)
- Ohio (9)
- Oregon (8)
- OregonTennessee (1)
- Seattle, WA (2)
- Tennessee (15)
- Texas (1)
- U.S. (7)
- United States (47)
- Utah (10)
- Washington (2)
- Wisconsin (3)
- acute respiratory illness (1)
- Buprenorphine (1)
- coronavirus disease (1)
- COVID-19 (1)
- COVID-19 Testing (1)
- COVID-19 vaccines (1)
- COVID-19–associated hospitalizations (1)
- disease transmission (1)
- Emergency Use Authorization (1)
- household transmission (1)
- Humans (1)
- influenza (1)
- Influenza, Human (1)
- Methadone (1)
- Mortality (1)
- Naltrexone (1)
- Pandemics (1)
- pandemics (1)
- presenteeism (1)
- race and ethnicity (1)
- respiratory infections (1)
- SARS-CoV-2 (2)
- SARS-COV-2 (1)
- secondary infection risk (1)
- severe acute respiratory syndrome coronavirus 2 (1)
- teleworking (1)
- Treatment (1)
- trends (1)
- United States (1)
- Vaccine safety (1)
- viral culture (1)
- viruses (1)
- workplaces (1)
- :Miller, E. Kathryn ;Linder, JodellAugust 06 2015 | J Allergy Clin Immunol. 137(3):734-743.e1:BackgroundRhinovirus is linked to asthma exacerbations and chronic obstructive pulmonary disease exacerbations in adults. The severity and rates of rh...
- :Esbenshade, Jennifer C. ;Edwards, Kathryn M.February 08 2013 | Infect Control Hosp Epidemiol. 34(4):373-378:BackgroundHealthcare-associated transmission of respiratory viruses is a concerning patient safety issue.DesignSurveillance for influenza virus among ...
- :Prill, Mila M. ;Iwane, Marika K.Mar 2012 | Pediatr Infect Dis J. 31(3):235-240:BackgroundHuman coronaviruses (HCoVs) have been detected in children with upper and lower respiratory symptoms but little is known about their relatio...
- :Talbot, H. Keipp ;Coleman, Laura A.Apr 23 2015 | BMC Infect Dis. 15.:BackgroundLittle is known about factors associated with maintenance of hemagglutinin inhibition (HAI) antibodies after influenza vaccination in older ...
- :Hartman, Lauren ;Zhu, YuweiFebruary 13 2018 | J Am Geriatr Soc. 66(3):467-472:ObjectiveTo describe factors associated with provider-ordered influenza testing among hospitalized adults.DesignInformation on patient demographics, s...
- :Coleman, Laura A. ;Mishina, MargaritaJun 14 2016 | Oncotarget. 2016; 7(24):35512-35521:The relationship between age, vitamin D status, expression and functionality of the vitamin D receptor (VDR), and key genes in the vitamin D pathway i...
- :Griffin, Marie R. ;Monto, Arnold S.Aug 12 2011 | PLoS One. 2011; 6(8).:We estimated the effectiveness of four monovalent pandemic influenza A (H1N1) vaccines (three unadjuvanted inactivated, one live attenuated) available...
- :Fisher, Kiva A. ;Olson, Samantha M.May 2021 | Influenza Other Respir Viruses. 15(3):345-351:BackgroundSymptoms of mild COVID‐19 illness are non‐specific and may persist for prolonged periods. Effects on quality of life of persistent poor ...
- :Ahmed, Faruque ;Nowalk, Mary Patricia12 2023 | Emerg Infect Dis. 2023; 29(12):2442-2450:Both SARS-CoV-2 and influenza virus can be transmitted by asymptomatic, presymptomatic, or symptomatic infected persons. We assessed effects on work a...
- :Chung, Jessie R. ;Flannery, BrendanJanuary 05 2016 | Pediatrics. 137(2):1-10:BACKGROUNDFew observational studies have evaluated the relative effectiveness of live attenuated (LAIV) and inactivated (IIV) influenza vaccines again...
- :Self, Wesley H. ;Grijalva, Carlos G.May 2012 | Emerg Infect Dis. 18(5):863-865.:To determine the number of emergency department visits attributable to influenza A(H1N1)pdm09 in Davidson County, Tennessee, USA, we used active, popu...
- :Patel, Manish ;Chen, JufuApril 29 2020 | Emerg Infect Dis. 26(8):1720-1730:Increasing use of immunosuppressive biologic therapies poses a challenge for infectious diseases. Immunosuppressed patients have a high risk for influ...
- :Woodruff, Rebecca C. ;Campbell, Angela P.1 2022 | Pediatrics. 149(1):Objectives:Describe population-based rates and risk factors for severe COVID-19 (i.e., intensive care unit admission, invasive mechanical ventilation,...
- :Chow, Eric J. ;Rolfes, Melissa A.August 25 2020 | Ann Intern Med. 173(8):605-613:Background:Influenza may contribute to the burden of acute cardiovascular events during annual influenza epidemics.Objective:To examine acute cardiova...
- :Petrie, Joshua G. ;Martin, Emily T.6 27 2019 | Vaccine. 37(29):3849-3855:Background:Frailty is an important physiologic factor in studies of influenza and influenza vaccines carried out in older adults and hospitalized popu...
- :Talbot, H. Keipp ;Hopkins, Robert H.November 19, 2021 | ACIP meeting COVID-19 Vaccines:05-COVID-Talbot-508.pdf
- :Talbot, H. Keipp ;Hopkins, Robert H.June 23, 2022 | ACIP meeting COVID-19 Vaccines:04-COVID-Talbot-508.pdf
- :Talbot, H. KeippJune 22, 2022 | ACIP meeting Influenza:01-influenza-talbot-508.pdf
- :Talbot, H. KeippJanuary 12, 2022 | ACIP meeting Influenza:01-influenza-talbot-508.pdf
- :Talbot, H. Keipp ;Hopkins, Robert H.September 22, 2021 | ACIP meeting COVID-19 Vaccines:COVID-Talbot-508.pdf
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.